{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:50:52Z","timestamp":1785887452031,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","award":["(2018-0014)"],"award-info":[{"award-number":["(2018-0014)"]}],"id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.urology.2018.11.037","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T12:49:10Z","timestamp":1544618950000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis\/Bladder Pain Syndrome: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Hyun Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Whan","family":"Doo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Seob","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Yeon","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli Jongchan","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-5712","authenticated-orcid":false,"given":"Bora","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-3610","authenticated-orcid":false,"given":"Jae Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.11.037_bib0001","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMra032662","article-title":"Management of overactive bladder","volume":"350","author":"Wood","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2018.11.037_bib0002","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/nau.23477","article-title":"The economic burden of overactive bladder in the United States: a systematic literature review","volume":"37","author":"Powell","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.11.037_bib0003","first-page":"11","article-title":"Social, economic, and health utility considerations in the treatment of overactive bladder","volume":"2","author":"Sacco","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0004","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment","volume":"193","author":"Ann Gormley","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0005","first-page":"41","article-title":"Management of refractory overactive bladder","volume":"65","author":"Giarenis","year":"2013","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.urology.2018.11.037_bib0006","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s11255-015-1125-7","article-title":"The safety and efficiency of onabotulinumtoxinA for the treatment of overactive bladder: a systematic review and metaanalysis","volume":"47","author":"Sun","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2018.11.037_bib0007","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","article-title":"Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study","volume":"49","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0008","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0009","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.eururo.2012.01.046","article-title":"Spread of onabotulinumtoxinA after bladder injection. experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action","volume":"61","author":"Coelho","year":"2012","journal-title":"Eurn Assoc Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0010","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s11255-016-1295-y","article-title":"Efficacy and safety of botulinum toxin injection for interstitial cystitis\/bladder pain syndrome: a systematic review and metaanalysis","volume":"48","author":"Shim","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2018.11.037_bib0011","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/21681805.2015.1121406","article-title":"Intravesical instillation of onabotulinum toxin A embedded in inert hydrogel in the treatment of idiopathic overactive bladder: a double-blind randomized pilot study","volume":"50","author":"Krhut","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0013","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0014","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4065\/84.8.702","article-title":"Botulinum A toxin\/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1\/2 study","volume":"84","author":"Petrou","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2018.11.037_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/luts.12214","article-title":"Advances in intravesical therapy for bladder pain syndrome (BPS)\/interstitial cystitis (IC)","volume":"10","author":"Meng","year":"2018","journal-title":"Lower Urin Tract Symptoms"},{"key":"10.1016\/j.urology.2018.11.037_bib0016","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","article-title":"Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats","volume":"172","author":"Chuang","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","article-title":"Drug insight: biological effects of botulinum toxin A in the lower urinary tract","volume":"5","author":"Chancellor","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2018.11.037_bib0018","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/nau.22598","article-title":"The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: a systematic review and meta-analysis","volume":"34","author":"Cui","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2018.11.037_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009122","article-title":"Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison","volume":"6","author":"Freemantle","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.urology.2018.11.037_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bju.13945","article-title":"Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis","volume":"120","author":"Drake","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.11.037_bib0021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0090-4295(02)02281-1","article-title":"Intravesical liposome administration\u2014A novel treatment for hyperactive bladder in the rat","volume":"61","author":"Fraser","year":"2003","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518313074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518313074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:43:35Z","timestamp":1565239415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518313074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":21,"alternative-id":["S0090429518313074"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.11.037","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis\/Bladder Pain Syndrome: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}